Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries India Globalization Capital Inc (NY: IGC ) 0.4032 +0.0022 (+0.55%) Streaming Delayed Price Updated: 3:21 PM EDT, Jun 20, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 166,707 Open 0.4020 Bid (Size) 0.4026 (1) Ask (Size) 0.4032 (2) Prev. Close 0.4010 Today's Range 0.4012 - 0.4100 52wk Range 0.2501 - 0.9099 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Execs Slated to Present at Upcoming Ascendiant Capital Markets Event June 18, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets June 18, 2024 From IGC Pharma, Inc. Via Business Wire Performance YTD +46.09% +46.09% 1 Month -25.21% -25.21% 3 Month +17.04% +17.04% 6 Month +36.22% +36.22% 1 Year +36.63% +36.63% More News Read More Hedge Fund Settles At $2.25M With SEC For Exposed Short Seller Deal, 2 Cannabis Stocks Affected June 13, 2024 Via Benzinga Topics Cannabis Regulatory Compliance Exposures Cannabis Legal Regulatory 12 Health Care Stocks Moving In Tuesday's Pre-Market Session June 11, 2024 Via Benzinga BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Announces Publication of Key Study in European Journal June 10, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence IGC Pharma Publishes Study in European Society of Medicine Investigating the Impact of CYP2C9 Genetic Polymorphism on Pharmacokinetics of Delta 9 Tetrahydrocannabinol June 10, 2024 From IGC Pharma, Inc. Via Business Wire 12 Health Care Stocks Moving In Tuesday's After-Market Session June 04, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session May 31, 2024 Via Benzinga BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Initiates Patient Enrollment in Phase 2 Trial Investigating IGC-AD1 May 28, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1 May 28, 2024 From IGC Pharma Inc. Via Business Wire BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Management Hosting Meetings at Upcoming BIO International Convention 2024 May 22, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence IGC Pharma to Attend BIO International Convention 2024 May 21, 2024 From IGC Pharma Inc. Via Business Wire 6.7 Million Americans Live With Alzheimer’s – IGC Pharma Believes They Deserve Treatment Options Without Black Box Warnings May 09, 2024 Via News Direct 6.7 Million Americans Live With Alzheimer’s – IGC Pharma Believes They Deserve Treatment Options Without Black Box Warnings May 09, 2024 Via TheNewswire.com Topics Cannabis Exposures Cannabis Product Safety 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 01, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday May 01, 2024 Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday April 29, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's After-Market Session April 16, 2024 Via Benzinga BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Shares Positive Interim Results on IGC-AD1 for Agitation in Alzheimer’s April 16, 2024 Via Investor Brand Network Topics Artificial Intelligence Cannabis Exposures Artificial Intelligence Cannabis IGC Pharma Says Cannabinoid-Based Drug Candidate Provides Fast Relief With Fewer Side Effects For Alzheimer's-Associated Agitation April 16, 2024 Via Benzinga IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two April 16, 2024 From IGC Pharma, Inc. Via Business Wire Who's Who In Cannabis: Latest Executive Changes You Should Know About April 15, 2024 Via Benzinga BioMedNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Adds AI Expert to Support Development of Phase 2 Clinical Trial April 09, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence IGC Pharma Adds Advisor in Artificial Intelligence April 09, 2024 From IGC Pharma, Inc. Via Business Wire IGC Pharma Releases Positive Interim Analysis Of Its Ongoing Phase 2 Trial In Alzheimer's Research April 03, 2024 Via News Direct Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
